Institutional investors control 53% of Novavax, Inc. (NASDAQ:NVAX) and were rewarded last week after stock increased 6.3% [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Institutional investors were rewarded last week after the stock increased 6.3%, which further boosted the one-year return to shareholders, currently standing at 65%. Insider ownership in Novavax, Inc. is less than 1%, which is a relatively low level of ownership. However, it is still positive that board members own shares, as it signals that leadership is thinking like the true owners of the company. Institutional investors own 53% of Novavax, Inc. (NASDAQ:NVAX), making them the largest shareholder group in the company. The general public, including retail investors, own 37% of Novavax, Inc., while public companies own 4.1% of the shares on issue. Given the large stake in the stock by institutions, Novavax's stock price might be vulnerable to their trading decisions A total of 18 investors have a majority stake in the company with 50% ownership Using data from analyst forecasts alongside ownership research, one can better assess the future performance of a company Every
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million MilestonePR Newswire
- Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates [Yahoo! Finance]Yahoo! Finance
- NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines [Yahoo! Finance]Yahoo! Finance
- Novavax, Inc. (NASDAQ: NVAX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock.MarketBeat
NVAX
Earnings
- 11/12/24 - Beat
NVAX
Sec Filings
- 1/3/25 - Form 4
- 1/2/25 - Form 4
- 1/2/25 - Form 4
- NVAX's page on the SEC website